AI Tool Predicts Alzheimer’s Disease Progression with High Accuracy
Researchers from the University of Cambridge have developed a tool using AI that can predict whether a person with early dementia symptoms will remain stable or progress to Alzheimer’s disease. This groundbreaking AI tool leverages cognitive tests and MRI scan data to make its predictions, significantly enhancing early diagnosis and patient care.
Development and Testing of the AI Tool
The Cambridge researchers utilized cognitive tests and MRI scan data from over 400 individuals in a U.S.-based research group to create their AI tool. They then validated the tool using data from an additional 600 participants from the same research group, along with 900 participants from memory clinics in the U.K. and Singapore.
“AI models are only as good as the data they are trained on,” explained Zoe Kourtzi, PhD, professor of experimental psychology and deputy head of research in the Department of Psychology at the University of Cambridge. “To ensure our model’s potential for adoption in healthcare, we trained and tested it on routinely collected data from both research cohorts and actual memory clinic patients, demonstrating its generalizability to real-world settings.”
AI Tool Outperforms Current Standards
The tool has shown remarkable accuracy, distinguishing between study participants with mild cognitive impairment who remained stable and those who progressed to Alzheimer’s disease within three years. It was able to identify 82% of participants who developed Alzheimer’s and 81% who did not, based solely on MRI scans and cognitive tests.
This performance is nearly three times more accurate than current diagnostic methods. “We’ve developed a tool that is much more sensitive than existing approaches at predicting whether someone will progress from mild symptoms to Alzheimer’s,” said Kourtzi.
“This has the potential to significantly improve patient well-being by identifying those who need the most care and reducing anxiety for those predicted to remain stable. It will also help alleviate healthcare pressures by reducing unnecessary diagnostic tests.”
Expert Opinions and Future Validation
Manisha Parulekar, MD, director of the Division of Geriatrics at Hackensack University Medical Center, lauded the AI tool’s development as a significant breakthrough. “Diagnosing Alzheimer’s disease in its early stages can be challenging. This tool could guide treatment decisions and help patients and their families plan for the future,” Parulekar said. She emphasized the importance of validating the AI tool in larger and more diverse populations to ensure its accuracy and generalizability.
David Merrill, MD, PhD, a geriatric psychiatrist and director of the Pacific Neuroscience Institute’s Pacific Brain Health Center, highlighted the tool’s potential in clinical settings. “This study demonstrates the usefulness of AI in creating accurate predictive models of dementia. It’s crucial to predict which patients need rapid intervention to prevent progression to full-blown dementia,”.
Implications for Healthcare
The development of this AI tool marks a significant advancement in the early diagnosis and management of Alzheimer’s disease. By accurately predicting disease progression. It enables timely and targeted interventions, ultimately improving patient outcomes and optimizing healthcare resources.
As the tool undergoes further validation, it represents a promising step forward in the fight against Alzheimer’s, offering hope for more effective and efficient patient care.
Originally posted on OpenDataScience.com
Read more data science articles on OpenDataScience.com, including tutorials and guides from beginner to advanced levels! Subscribe to our weekly newsletter here and receive the latest news every Thursday. You can also get data science training on-demand wherever you are with our Ai+ Training platform. Interested in attending an ODSC event? Learn more about our upcoming events here.
